Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)
CVS Health Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) increased by 10.2% to $9.98B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 48.2%, from $6.73B to $9.98B. Over 4 years (FY 2020 to FY 2024), Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) shows an upward trend with a 38.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An unexplained increase may signal inefficiencies in collections or a buildup of non-core assets, while a decrease generally reflects effective management of miscellaneous receivables.
Detailed definition
This represents amounts owed to the company from non-core business activities, excluding standard trade receivables from...
Peer comparison
Standard line item across most industries; peers typically group this under other current assets.
current_assets_other_receivables_net_currentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.25B | $2.77B | $3.39B | $2.53B | $2.51B | $2.65B | $3.45B | $2.32B | $2.61B | $2.60B | $3.89B | $3.53B | $4.63B | $6.73B | $7.97B | $8.76B | $9.05B | $9.98B |
| QoQ Change | — | +23.2% | +22.5% | -25.3% | -0.9% | +5.5% | +30.3% | -32.7% | +12.4% | -0.2% | +49.6% | -9.3% | +31.3% | +45.3% | +18.3% | +10.0% | +3.3% | +10.2% |
| YoY Change | — | — | — | — | +11.7% | -4.3% | +1.8% | -8.3% | +3.9% | -1.7% | +12.9% | +52.2% | +77.8% | +158.6% | +104.6% | +148.2% | +95.4% | +48.2% |
Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) at Other Companies
Frequently Asked Questions
- What is CVS Health's other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)?
- CVS Health (CVS) reported other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) of $9.98B in Q3 2025.
- How has CVS Health's other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) changed year-over-year?
- CVS Health's other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) increased by 48.2% year-over-year, from $6.73B to $9.98B.
- What is the long-term trend for CVS Health's other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)?
- Over 4 years (2020 to 2024), CVS Health's other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) has grown at a 38.0% compound annual growth rate (CAGR), from $2.20B to $7.97B.
- What does other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) mean?
- Money owed to the company from sources other than primary customer sales, adjusted for potential non-payment.